News

AddToAny

Google+ Facebook Twitter Twitter

MRI for prostate cancer screening?

A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately.

MRI for prostate cancer screening?

The current prostate-specific antigen (PSA) test is considered too unreliable for population screening.

But researchers will investigate whether MRI could be used to screen men to pick up cancers earlier and more reliably, potentially helping to save lives.

They will also study whether, combined with cutting-edge techniques – including genomics and machine learning – MRI scans can replace prostate biopsies.

A group, led by Mark Emberton from University College London, working with King’s College London, Imperial College London and 12 industry partners, aims to recruit 1000 men with medium- to high-risk cancers to find out if MRI can be combined with other high-tech diagnostic tests to predict progression.

The study is being launched with funding of £4.1m from the Medical Research Council and £1m from Cancer Research UK.

Related Articles

Journal-based learning exercises - February 2019

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Download PDF

Diagnosing prostate cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour higher-risk cancer in their prostate glands, according to new research.

Breath test to detect cancer

A clinical trial has been launched to see if a breath test could detect the presence of cancer.

One step ahead of cancer

In the UK, one in two of us can expect to get cancer in our lifetimes. With such a high disease burden, efforts to prevent cancer are at least as important as efforts to treat it. 

Top